Additional European Equity News

AstraZeneca (AZN LN) - Co. provides an update on Resolute Phase III Trial; Fasenra trial did not meet primary endpoint; will analyse full data set from the trial to further understand results. Elsewhere, Saphnelo self-administration TULIP-SC Phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on an interim analysis. (AstraZeneca) 

Barratt Redrow (BDEV LN) - FY25 (GBP): Adj. Pretax 488.3mln (prev. 591.6mln Y/Y), Revenue 5.58bln (prev. 4.17bln Y/Y). Affirms FY26 home completions. Notes that moving into FY26, affordability, uncertainty in macro environment and weak consumer confidence remain challenging. (Newswires) 

Games Workshop (GAW LN) - Declared a dividend of 85p. Notes that trading is in line with Q1. (Newswires) 

Sodexo (SW FP) / Shell (SHEL LN) - Co’s renew 5-year collaboration for workplace services starting 1 Nov 2025. (Newswires)

STMicroelectronics (STMPA FP) - Co. to advance next-gen chip manufacturing tech with new PLP pilot line. (Newswires) 

Thyssenkrupp (TKA GY) upgraded to Hold at DZ Bank 

Inditex (ITX SM) upgraded to Buy from Neutral at UBS